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ABSTRACT 
Eicosapentaenoic (EPA, 20:5), docosahexaenoic (DHA, 22:6) and docosapentaenoic (DPA, 22:5) 
acids are omega-3 polyunsaturated fatty acids (n-3 PUFA) obtained from dietary consumption of 
fish oils that potentially alleviate the symptoms of a range of chronic diseases. We focus here on 
the plasma membrane as a site of action and investigate how they affect molecular organization 
when taken up into a phospholipid. All atom MD simulations were performed to compare 
1-stearoyl-2-eicosapentaenoylphosphatylcholine (EPA-PC, 18:0-20:5PC), 
1-stearoyl-2-docosahexaenoylphosphatylcholine (DHA-PC, 18:0-22:6PC), 
1-stearoyl-2-docosapentaenoylphosphatylcholine (DPA-PC, 18:0-22:5PC) and, as a 
monounsaturated control, 1-stearoyl-2-oleoylphosphatidylcholine (OA-PC, 18:0-18:1PC) 
bilayers. They were run in the absence and presence of 20 mol% cholesterol. Multiple double 
bonds confer high disorder on all three n-3 PUFA. The different number of double bonds and 
chain length for each n-3 PUFA moderates the reduction in membrane order exerted (compared 
to OA-PC, 𝑆?̅?𝐷 = 0.152). EPA-PC (𝑆?̅?𝐷 = 0.131) is most disordered, while DPA-PC (𝑆?̅?𝐷 = 
0.140) is least disordered. DHA-PC (𝑆?̅?𝐷 = 0.139) is, within uncertainty, the same as DPA-PC. 
Following the addition of cholesterol, order in EPA-PC (𝑆?̅?𝐷 = 0.169), DHA-PC (𝑆?̅?𝐷 = 0.178) 
and DPA-PC (𝑆?̅?𝐷 = 0.182) is increased less than in OA-PC (𝑆?̅?𝐷 = 0.214). The high disorder of 
n-3 PUFA is responsible, preventing the n-3 PUFA-containing phospholipids from packing as 
close to the rigid sterol as the monounsaturated control. Our findings establish that EPA, DHA 
and DPA are not equivalent in their interactions within membranes, which possibly contributes to 
differences in clinical efficacy. 
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Abbreviations 
 
1
docosahexaenoic acid (DHA), docosapentaenoic (DPA), eicosapentaenoic acid (EPA), electron 
density profile (EDP), number density profile (NDP), oleic acid (OA), omega-3 polyunsaturated 
fatty acid(s) (n-3 PUFA), phosphatidylcholine (PC), radial distribution function (RDF), stearic 
acid (SA), 1,2-dioleolylphosphatidylcholine (DOPC), 1-palmitoyl-2-oleoylphosphatidylcholine 
(POPC), 1-stearoyl-2-docosahexaenoylphosphatidylcholine (DHA-PC), 
1-stearoyl-2-docosapentaenoylphosphatidylcholine (DPA-PC), 
1-stearoyl-2-eicosapentaenoylphosphatidylcholine (EPA-PC), 
1-stearoyl-2-oleoylphosphatidylcholine (OA-PC) 
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1. INTRODUCTION 
 Long chain omega-3 polyunsaturated fatty acids (n-3 PUFA)
1
 are a distinct class of fatty 
acids that have multiple double bonds, with the last double bond being located 3 carbons from 
the terminal methyl (n or ω) end of the chain [1]. They began to attract attention in the 1970’s 
when a low incidence of cardiovascular disease was noted in the Inuit population who consumed 
a diet rich in oily fish that contain an abundance of n-3 PUFA [2]. Since then many more health 
benefits have been discovered including the treatment of neurological problems [3], relief of the 
symptoms of inflammatory disorders [4], improvements in whole body metabolism [5] and 
prevention of the progress of certain cancers [6]. The major source of long chain n-3 PUFA in 
the diet is oily cold-water fish and/or extracted oil supplements [1]. Eicosapentaenoic acid (EPA, 
20:5) with 20 carbons and 5 double bonds at the 5, 8, 11, 14 and 17 positions and 
docosahexaenoic acid (DHA, 22:6) with 22 carbons and 6 double bonds at the 4, 7, 10, 13, 16 
and 19 positions are the primary ones. Present in smaller concentration, and to which EPA often 
converts, is docosapentaenoic acid (DPA, 22:5) with 22 carbons and 5 double bonds at the 7, 10, 
13, 16 and 19 positions. DPA has only recently begun to be the subject of research, in contrast to 
EPA and DHA that have been widely studied [7]. Although all three n-3 PUFA are similar in 
chemical structure, whether they have similar, unique or complementary impact upon health 
remains a matter of debate [8].  
 A complete explanation of the mode of action for n-3 PUFA currently does not exist. 
Modulation of the organization of plasma membranes following the uptake of n-3 PUFA into 
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phospholipids is among the potential mechanisms that have been identified [9-11]. The basic idea 
is a variation on the lipid raft concept [12]. According to this model, predominantly saturated 
sphingolipids and cholesterol segregate into tightly packed nanodomains that coalesce into 
functional microdomains (rafts) within a surrounding phospholipid environment that is less 
ordered. By incorporating into membrane phospholipids, highly disordered n-3 PUFA that have 
an aversion for cholesterol are then proposed to manipulate the composition and structure of the 
domains. One example of a scenario envisaged, for instance, has the introduction of n-3 
PUFA-containing phospholipids into a raft displacing cholesterol and breaking apart the domain 
[11]. Detergent extraction assays and imaging studies performed on cells either treated with n-3 
PUFA or obtained following a n-3 PUFA enriched diet support the general premise that n-3 
PUFA are taken up into rafts and affect their size [13,14]. Changes in the levels of other fatty 
acids due to cellular metabolism, however, complicate interpretation. A series of studies on 
biomimetic membranes of controlled composition carried out in our laboratories have started to 
provide insight [15-18]. They established that the partitioning of an n-3 PUFA-containing 
phospholipid between more ordered raft-like and less ordered non-raft environments is sensitive 
to molecular structure. A much greater tendency for DHA- than EPA-containing 
phosphatidylcholine (PC) to infiltrate raft-like domains was revealed, which we attribute to a 
differential in the disorder associated with DHA relative to EPA and speculate may indicate a 
variance in bioactivity. To better understand this behavior and the possible role that the structure 
of an individual n-3 PUFA plays in determining biological activity, we have run atomistic MD 
simulations to make a direct comparison of EPA, DHA and DPA and their interaction with 
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cholesterol. 
 All atom MD simulation opens up a perspective on molecular structure and dynamics 
within lipid membranes that is unprecedented in detail [19]. The reliability of this computational 
method has been ascertained in tests on well-characterized systems that successfully reproduce 
experimental measurements. It is an approach that has been tremendously influential in 
developing a comprehension of the physical properties of PUFA-containing phospholipids. 
Simulations published for DHA-containing PC bilayers more than a decade ago were 
instrumental in showing that the polyunsaturated chain is highly flexible, rapidly undergoing 
isomerization between conformations that include extended and bent configurations [20-22]. A 
reduced energy barrier for rotation about the single bonds in the recurring =C-C-C= unit 
possessed by PUFA is responsible, debunking an alternative view that the rigidity of multiple 
bonds would produce low flexibility. Subsequent analysis of simulations on a 
1-stearoyl-2-docosahexaenoylphosphatidylcholine (18:0-22:6PC, DHA-PC) bilayer in the 
presence of cholesterol showed that the steroid moiety prefers close proximity to the saturated 
stearic acid (SA) chain over the polyunsaturated DHA chain [23]. This finding corroborates an 
arrangement inferred from experimental measurements of the orientation of cholesterol and its 
solubility in polyunsaturated membranes [24]. Phenomenal disorder that pushes cholesterol away 
is what distinguishes PUFA and renders membrane architecture particularly responsive to their 
presence. 
 An investigation of how molecular organization in lipid bilayers is affected by differences 
in the structure of EPA, DHA and DPA is presented here. To this end, we performed atomistic 
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MD simulations comparing 1-stearoyl-2-eicosapentaenoylphosphatidylcholine (18:0-20:5PC, 
EPA-PC), 1-stearoyl-2-docosahexaenoylphosphatidylcholine (18:0-22:6PC, DHA-PC, 
1-stearoyl-2-docosapentaenoylphosphatidylcholine (18:0-22:5PC, DPA-PC) and 
1-stearoyl-2-oleoylphosphatidylcholine (18:0-18:1PC, OA-PC) bilayers. Their molecular 
structure, together with cholesterol, is shown in Figure 1. DHA-PC, EPA-PC and DPA-PC are  
 
 
Figure 1 Molecular structure of OA-PC, DPA-PC, DHA-PC, EPA-PC and cholesterol. 
 
 
representative of a phospholipid into which n-3 PUFA have been taken up in the plasma 
membrane, while OA-PC serves as a monounsaturated control [25]. In a structural motif that is 
typical of phospholipids found in animal membranes, they all have SA, a common saturated fatty 
acid, at the sn-1 position and an unsaturated fatty acid at the sn-2 position. The simulations were 
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run on single component membranes and in the presence of 20 mol% cholesterol to characterize 
interaction with the sterol for each n-3 PUFA. Supplementary solid state 
2
H NMR experiments 
employing analogs of the phospholipids perdeuterated in the sn-1 chain were conducted for 
validation. 
 
2. MATERIALS AND METHODS 
2.1 MD simulations 
Atomistic MD simulations were performed on DHA-PC, EPA-PC, DPA-PC and OA-PC 
bilayers in the absence and presence of 20 mol% cholesterol. They were run in the constant 
particle number, pressure and temperature (NPT) ensemble. There were 98 PC molecules in the 
single component membrane simulations, and 80 PC molecules and 20 cholesterol molecules in 
the two-component membrane simulations. In each case, the membrane was hydrated with 2000 
water molecules. The initial structure of OA-PC, OA-PC + cholesterol, DHA-PC and DHA-PC + 
cholesterol bilayers was assembled with the CHARMM-GUI Membrane Builder [26]. Then, by 
modifying the DHA chain on DHA-PC molecules, the initial structure of EPA-PC + cholesterol 
and DPA-PC + cholesterol bilayers was generated from our assembled DHA-PC + cholesterol 
bilayer. Locating the corresponding lipid molecule into a bilayer grid with a customized script 
created the initial structure of EPA-PC and DPA-PC bilayers. This approach avoided atom/chain 
conflicts that appear in the initial structure when it is directly modified from the assembled 
DHA-PC bilayer. All simulations were run using the CHARMM C36p force field [27]. 
Non-bonded (van der Waals and short-range electrostatic) interactions were gradually switched 
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off at 10 Å, and the long-range electrostatic interactions were calculated using the particle-mesh 
Ewald method [28]. The membranes were equilibrated with the standard CHARMM-GUI 
six-step process over 200 ps [26] during which constraints on lipids were gradually released [29]. 
Production runs of our simulations were performed with NAMD [30] on the Big Red II 
super computer at Indiana University. Each one was run over 200 ns using a time step of 2 fs, 
with the first 20 ns considered to be equilibration. In all simulations, periodic boundary 
conditions were applied to a rectangular box on which the x and y dimensions (in the plane of the 
membrane) were kept equal while the z dimension (in the direction of the membrane normal) 
was varied independently. The temperature was kept at 37 °C and the pressure was maintained at 
1 atm by the Langevin dynamics piston method [31]. Analyses of simulations, including 
calculating order parameters and densities of atoms in 1- and 3-dimensions were achieved with 
customized Tcl script executed in the visual molecular dynamics (VMD) program [32]. 
Snapshots of bilayers and illustrations were also created with VMD, and rendered by blender. 
 
2.2 Solid state 
2
H NMR 
 Details of solid state 
2
H NMR experiments are provided in Supporting Information. 
 
3. RESULTS AND DISCUSSION 
Biological membranes contain a diverse array of lipids. Phospholipids vary in head group 
and chain composition – number of carbons and number and location of double bonds. These 
variations in molecular structure modify physical properties and molecular organization within a 
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membrane in a complex manner. The aim of our study is to focus on three n-3 PUFA - EPA, 
DHA and DPA. With MD simulations performed on EPA-PC, DHA-PC and DPA-PC, we 
observe how they affect the molecular organization of a phospholipid bilayer. OA-PC, a common 
monounsaturated phospholipid, is employed as a benchmark for comparison. 
 
3.1 Molecular organization in single component membranes  
 From our simulations on EPA-PC, DHA-PC and DPA-PC bilayers, differences in how 
each n-3 PUFA affects acyl chain order within membranes and the thickness of a bilayer were 
identified. 
3.1.1 Membrane order 
 The order parameter 𝑆𝐶𝐷 is a fundamental quantity describing the dynamics of acyl 
chain segments in a membrane that is accessible by MD simulations and solid state 
2
H NMR 
spectroscopy [33]. It is a measure of the anisotropy of motion for the C-H (H is replaced by 
2
H in 
2
H NMR experiments) bond on a methylene or methyl group in an acyl chain. The definition of 
the order parameter is 
𝑆𝐶𝐷 =
1
2
〈3 𝑐𝑜𝑠2 𝛽 − 1〉   (1) 
where 𝛽 is the angle between the C-H bond on a particular chain segment and the membrane 
normal about which the reorientation of the chain is axially symmetric [34]. The angular brackets 
signify a time average that is also taken over all the molecules in a simulation. In the case of 
methylene groups and the terminal methyl group, an average order parameter for the two and 
three C-H bonds in the respective segments is usually calculated. An exception is the two C-H 
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bonds on the methylene group at the C2 position of the sn-2 chain for which constraints on 
orientation due to the glycerol backbone lead to order parameters that are unequal [35]. A range 
0 ≤ |𝑆𝐶𝐷| ≤ 0.5 typically applies to the value for 𝑆𝐶𝐷 [18]. The upper limit corresponds to a 
methylene group undergoing fast axial rotation in an all-trans chain (𝛽 = 90°) while the lower 
limit corresponds to isotropic motion (𝛽 takes all angles) for a methylene or methyl group. 
Figure 2 (upper panel) shows the order parameter profiles obtained from simulation along 
the saturated SA chain at the sn-1 position in EPA-PC, DHA-PC, DPA-PC and OA-PC. They all 
display a form that is a signature for saturated phospholipid acyl chains in the lamellar liquid  
 
Figure 2 Order parameter profile along the sn-1 (upper panel) and -2 (lower panel) chains 
in OA-PC (red), DPA-PC (yellow), DHA-PC (blue) and EPA-PC (green) bilayers obtained from 
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MD simulations at 37°C. The uncertainty in the 𝑆𝐶𝐷 values is ≤±0.003, which was estimated 
from the standard error obtained treating each lipid molecule independently. 
 
crystalline phase [34]. In the top half of the chain the 𝑆𝐶𝐷 values exhibit a plateau region of 
approximately constant order (𝑆𝐶𝐷 ~ 0.2, C4-C8 positions), and then progressively decrease in 
the bottom half toward the terminal methyl group (𝑆𝐶𝐷 ~ 0.02, C18 position) near the center of 
bilayer. Reorientation is constrained by tighter packing in the upper portion where the chain is 
anchored at the hydrophilic interface, while in the lower portion there is increasingly less 
restriction to motion towards the free end at the foot of the chain. Inspection of the profiles 
reveals the reduction in order expected to accompany the presence of a polyunsaturated sn-2 
chain, which we quantify in terms of an average order parameter 𝑆?̅?𝐷 that represents the global 
effect on the entire sn-1 chain (Table 1). Among the PUFA-containing phospholipids, EPA-PC 
(𝑆?̅?𝐷 = 0.131) is the most disordered while DPA-PC (𝑆?̅?𝐷 = 0.140) is the least disordered. 
DHA-PC (𝑆?̅?𝐷 = 0.139) is, within uncertainty, the same as DPA-PC. They are all ~10% less 
ordered than monounsaturated OA-PC (𝑆?̅?𝐷 = 0.152). 
 
Table 1 Average order parameters 𝑆?̅?𝐷 for the sn-1 and -2 chains in OA-PC, DPA-PC, 
DHA-PC and EPA-PC membranes without and with 20 mol% of cholesterol. The uncertainty in 
the 𝑆?̅?𝐷 values is <±0.002, which was estimated from the standard error obtained treating each 
lipid molecule independently. 
 
Phospholipid 
𝑆?̅?𝐷 
sn-1 sn-2 
Without Cholesterol With cholesterol Without Cholesterol With cholesterol 
OA-PC 0.152 0.214 0.119 0.170 
DPA-PC 0.140 0.182 0.047 0.062 
DHA-PC 0.139 0.178 0.030 0.041 
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EPA-PC 0.131 0.169 0.032 0.044 
 
The trends seen here are consistent with those observed experimentally by 
2
H NMR with 
analogs of PC deuterated in the sn-1 chain. Order parameter profiles published for the SA sn-1 
chain in a series of PC membranes as a function of the level of unsaturation in the sn-2 chain 
demonstrated that increasing the number of double bonds from 1 to 3 substantially decreases 
order [36]. Thereafter the changes in order on increasing the number of double bonds from 3 to 6 
are modest. The hierarchy of disorder EPA-PC (most disordered) > DHA-PC ≥ DPA-PC (least 
disordered) identified by simulation qualitatively reproduces the variation of the average order 
parameter previously measured by us using moment analysis [37] and of the smoothed order 
parameter profiles constructed from FFT depaked spectra in the current work (Figures S1, S2 and 
Table S1 in Supporting Information). An order parameter profile has not been reported, as far as 
we know, for DPA-PC before. To give context to the potential significance of the modest 
difference in order parameter observed here between n-3 PUFA-containing phospholipids, order 
parameters that differ by a comparable amount were reported in earlier work contrasting the 
properties for bilayers composed of n-3 vs. n-6 (where the last double is 6 carbons from the 
terminal methyl group) PUFA-containing phospholipids. [38,39]. 
The order parameters that were calculated for the unsaturated sn-2 chain in EPA-PC, 
DHA-PC, DPA-PC and OA-PC are plotted as function of position in Figure 2 (lower panel). Not 
surprisingly, there is a big difference between the OA chain and PUFA chains. The OA chain in 
OA-PC has a profile that is similar to the SA sn-1 chain, apart from positions C8-C11 where 
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there is big drop in the magnitude of 𝑆𝐶𝐷. This phenomenon was first observed experimentally 
and is understood [40,41]. A localized region of enhanced segmental motion within the OA chain 
is not the reason for the reduced order parameters. The configuration of the chain around the 
rigid cis double bond, instead, produces a most probable orientation for which the order 
parameters of the C-H bonds on the chain segments at (C9 and C10) and flanking (C8 and C11) 
the double bond are inherently low – i.e. 𝛽 takes angles near the “magic” angle (54.7°) at which 
the second order Legendre polynomial in the definition of the order parameter (eq. 1) goes to 
zero. 
Compared to the OA chain in OA-PC, the order parameters for the PUFA chain in 
EPA-PC, DHA-PC and DPA-PC are much lower. They are less than 0.05 throughout the bottom 
two-thirds of the chain (C7 to the end), which is comparable to the value of 𝑆𝐶𝐷 for the highly 
mobile methyl group at the free end of a chain. An almost uniform distribution from 0 to 180° 
for the value of the angle 𝛽 that the C-H bonds make with the bilayer normal is responsible. 
The truly high disorder implied is the result of the shallow energy barrier to rotation about C-C 
bonds in the repeating =CH-CH2-CH= motif that distinguish PUFA with their multiple double 
bonds from less unsaturated fatty acids [42]. This behavior is well documented by simulation and 
experiment in the case of DHA [26,43-45]. Higher order exists in the uppermost portion of the 
PUFA chains before the sequence of double bonds begins. The effect is most pronounced in 
DPA where the first double bond does not occur until carbon C7 (Figure 1). The order parameter 
(𝑆𝐶𝐷 ~ 0.17) at positions C3-5 of the DPA chain in DPA-PC approaches the value seen at the 
same positions for OA in OA-PC (𝑆𝐶𝐷 ~ 0.20) (Figure 3). A similar plateau-like region of 
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elevated order is found in the profile for neither DHA in DHA-PC nor EPA in EPA-PC. We 
attribute its presence in DPA to the removal of the double bond at the C4 position relative to 
DHA and to the addition of two methylene groups prior to the first double bond relative to EPA 
(Figure 1). In response, order parameters in the SA sn-1 chain are higher for DPA-PC than 
DHA-PC and, to greater extent, EPA-PC. The lower order of the SA chain in EPA-PC than 
DHA-PC indicates that, as we have previously surmised [37], the ordering associated with the 
loss of a double bond is more than compensated by the disordering associated with the 
shortening of the chain on replacing DHA by EPA. Whether this observation is specific to EPA 
vs. DHA or more generally applicable remains to be seen. 
3.1.2 Membrane thickness 
Electron density profiles (EDP) that were calculated across the membrane for EPA-PC, 
DHA-PC, DPA-PC and OA-PC are shown in Figure 3 (upper panel). They were generated from 
histograms of the atoms in lipids along the bilayer normal (z direction) that were weighted by the 
number of electrons associated with each atom. Because the area of membrane that was 
simulated is too small to undulate, the z direction in our system well represents the membrane 
normal [46]. In the EDP of each membrane, there is a dip in the middle (z = 0) of the bilayer 
reflecting where the highly disordered methyl groups at the end of acyl chains reside. The peaks 
on both sides correspond to the electron dense head group at the edge of the membrane and, as 
illustrated (Fig. 3, upper panel), approximate to the location of the phosphate group. Their 
separation is commonly taken to be the membrane thickness [47] and was used by us to 
determine the 𝐷𝐻𝐻 values listed in Table 2. The agreement with experimental data that exist in 
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the literature for OA-PC (38.7 Å) [48] and DHA-PC (37.9 Å) [38] is good (within 1 Å). As far 
we know 𝐷𝐻𝐻 has not been measured for EPA-PC and DPA-PC, although in the latter case a 
thickness has been reported from X-ray work for its n-6 isomeric counterpart DPA(n-6)-PC (37.9 
Å) [38]. 
 
Figure 3 EDP for all atoms (above) and the number density profile of the phosphorus atom 
(below) on the phospholipid in OA-PC, DPA-PC, DHA-PC and EPA-PC bilayers without 
cholesterol (upper panel) and with addition of 20 mol% cholesterol (lower panel). The phosphate 
curves are vertically scaled and shifted for clarity. Table 2 gives the differences in membrane 
thickness 𝐷𝐻𝐻 calculated from the separation of the phosphate peaks. 
 
It is generally recognized that introducing double bonds into a phospholipid chain causes 
a thinning of the bilayer [49]. A lipid chain with a double bond, and more markedly with 
multiple double bonds, is more disordered and occupies a larger cross-sectional area than a 
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saturated chain with same number of carbons. The result is a thinner bilayer. The measurements 
of membrane thickness obtained from our simulations conform to the gist of this view (Table 2). 
They demonstrate that DPA-PC, DHA-PC (22 carbons) and EPA-PC (20 carbons) with a 
polyunsaturated sn-2 chain are comparable in thickness or thinner than OA-PC (18 carbons) with 
a shorter monounsaturated sn-2 chain. As an aside, we point out that the values of 𝐷𝐻𝐻  
measured from the EDP generated from our simulations underscore that care should be exercised 
when relating the average order parameter for the saturated sn-1 chain (Table 1) to membrane 
thickness. The basic idea connecting the two parameters is that a more ordered sn-1 chain has a 
bigger projected length, corresponding to greater bilayer thickness [50]. However, despite an 
average order parameter for the SA sn-1 chain in DPA-PC that is almost 10% lower than in 
OA-PC, the thickness of the n-3 PUFA containing bilayer is slightly bigger. The length of the 
sn-2 chain is clearly a factor. 
 
 
OA-PC DPA-PC DHA-PC EPA-PC 
Pure 39.6 39.7 38.8 37.5 
With 
cholesterol 
44.2 42.9 42.2 40.7 
Change 4.6 3.2 3.4 3.2 
 
Table 2 Membrane thickness (DHH) measured from phosphate-phosphate distance (Å) for 
OA-PC, DPA-PC, DHA-PC and EPA-PC in the absence and presence of 20 mol% cholesterol. 
The uncertainty is ±0.09 Å, estimated from the standard error of the peak locations. 
 
3.2 Molecular organization in membranes containing cholesterol 
 From simulations run in the presence of 20 mol% cholesterol, we compared how acyl 
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chain order within the membrane and the thickness of the bilayer were affected in EPA-PC, 
DHA-PC and DPA-PC. To further assess interaction with the sterol, the location and orientation 
of cholesterol within the bilayers were determined and the distribution of each chain around the 
steroid moiety was mapped. 
3.2.1 Membrane order 
The addition of 20 mol% cholesterol to EPA-PC, DHA-PC and DPA-PC produces the 
anticipated increase in order within the bilayer [51]. Order parameters are elevated along the 
entire SA chain at sn-1 position in each case, reflecting the constraint upon reorientation imposed 
by the rigid sterol molecule (Figure 4, upper panel). The shape of the profile remains largely 
unchanged. There is still a relatively flat region of approximately constant order parameter in the 
upper portion of the chain before order drops off in the lower portion towards the terminal 
methyl group. As judged by estimates of the average order parameter (Table 1), all three n-3 
PUFA containing bilayers undergo essentially the same rise in order (∆𝑆?̅?𝐷 ≈ 0.040) due to 
cholesterol so that the hierarchy of order between them is retained - DPA-PC (𝑆?̅?𝐷 = 0.182) > 
DHA-PC (𝑆?̅?𝐷 = 0.178) > EPA-PC (𝑆?̅?𝐷 = 0.169). The sterol-induced ordering is less than seen 
for the SA chain in OA-PC (𝑆?̅?𝐷 = 0.214 and correspondingly ∆𝑆?̅?𝐷  = 0.062). A greater 
differential in order between the n-3 PUFA- and OA-containing bilayers results, which is 
apparent on inspection of the profiles obtained with (Fig. 4, upper panel) and without (Fig. 2, 
upper panel) cholesterol. It has similarly been surmised from experimental results presented in 
earlier studies there is a smaller increase in order due to cholesterol for polyunsaturated vs. 
monounsaturated bilayers [52,53]. 
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The response to the introduction cholesterol observed by simulation, moreover, captures 
the essence of the changes in order for the SA sn-1 chain exhibited in the 
2
H NMR experiments 
on the various membranes that we performed to provide validation (Figures S3, S4 and Table S1  
 
Figure 4 Order parameter profile along the sn-1 (upper panel) and -2 (lower panel) chains 
in OA-PC (red), DPA-PC (yellow), DHA-PC (blue) and EPA-PC (green) bilayers following the 
addition of 20 mol% cholesterol obtained from MD simulations at 37°C. The uncertainty in the 
𝑆𝐶𝐷 values is ≤±0.003, which was estimated from the standard error obtained treating each lipid 
molecule independently. A comparative plot directly showing the effects of cholesterol on each 
profile is presented in Figure S6 (Supporting Information). 
 
in Supporting Information). As with the simulated profiles, the experimentally derived profiles 
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for all three n-3 PUFA register a similar increase in order due the sterol that is smaller than for 
OA-PC.   
A substantially more modest increase in order occurs for the n-3 PUFA chain at the sn-2 
position in EPA-PC, DHA-PC and DPA-PC following the introduction of cholesterol than for the 
SA chain at the sn-1 position (Fig. 4, lower panel). The shift in average value for the order 
parameter (∆𝑆?̅?𝐷 < 0.015) is correspondingly smaller and comparable in each case (Table 1). 
There is little change in the overall shape of the profile. Despite the presence of the rigid steroid 
moiety, the n-3 PUFA chains are still highly disordered with order parameters that are low 
throughout much of their length (𝑆𝐶𝐷 < 0.08 in the bottom two thirds). High conformational 
flexibility, which allows PUFA chains to rapidly move through a diverse collection of 
configurations that include ones that have chain segments turning upside down, is responsible 
[23]. The chain segments in a PUFA chain at the sn-2 position are able to redistribute from the 
aqueous interfacial towards the hydrophobic interior in the presence of cholesterol with much 
less increase in order parameter than a saturated chain at the sn-1 position that is more restricted 
in conformation. In contrast, the order of the OA sn-2 chain in OA-PC is elevated to a much 
greater extent by cholesterol. It increases by an amount (∆𝑆?̅?𝐷  = 0.051) approaching that 
undergone by the saturated SA sn-1 chain, retaining the form of the profile observed in the 
absence of the sterol. The effect of cholesterol on the order parameter profile for the DHA sn-2 
chain in DHA-PC derived from our simulations parallels the results obtained from NMR spectra 
[53]. Experimental measurements of the order parameter in the OA sn-2 chain of OA-PC are too 
sparse to make a meaningful comparison, while we are unaware that order parameters in either 
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the EPA sn-2 chain of EPA-PC or DPA sn-2 chain of DPA-PC have been experimentally 
determined. 
3.2.2 Membrane thickness 
 A thickening of EPA-PC, DHA-PC and DPA-PC, as well as of OA-PC, that follows the 
introduction of cholesterol is evident in the EDP constructed in Figure 3 (lower panel). It is a 
manifestation of the condensing effect of the sterol - the projected length of phospholipid chains 
ordered by cholesterol is greater and the bilayer becomes thicker [54]. All three of the n-3 
PUFA-containing membranes undergo a comparable increase in thickness (∆𝐷𝐻𝐻 = 3.2-3.4 Å) 
that is less than the change undergone by the OA-containing membrane (∆𝐷𝐻𝐻 = 4.6 Å) (Table 
2). As would be expected, the magnitude of these changes qualitatively parallels the elevation in 
molecular ordering due to cholesterol (Table 1). In agreement with these simulation-based 
findings, that the sterol produces a smaller increase in the width of DHA-PC compared to 
OA-PC bilayers may be gleaned from reports of neutron and x-ray scattering data [53,54]. 
3.2.3 Location of cholesterol 
Cholesterol usually resides in a membrane with the hydroxyl group at one end of the 
tetracyclic ring near the aqueous interface while the short chain at the opposite end extends 
towards the center of the membrane [51]. An exception is bilayers that are thin (𝐷𝐻𝐻 < 30 Å) in 
which hydrophobic mismatch drives the sterol into the interior of membrane where it straddles 
both leaflets [49]. This latter situation does not apply to the systems in the current study. The 
partial EDP generated from the simulated data for [2,3,4]- and [25,26,27]-carbons on cholesterol 
in EPA-PC, DHA-PC, DPA-PC and OA-PC conform to the canonical arrangement (Fig. 5, upper 
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and middle panels). They place the head ([2,3,4]-carbons) and tail ([25,26,27]-carbons) of the 
sterol, respectively, just below the surface and in the middle of the bilayer. 
 
 
 
Figure 5 Carbon number density profile for the [2,3,4]-carbons (head group) and 
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[25,26,27]-carbons (tail) on cholesterol (upper and middle panels, respectively) and histogram of 
the orientation of cholesterol (vector connecting the C13-C10 carbons) relative to the bilayer 
normal (lower panel) in OA-PC, DPA-PC, DHA-PC and EPA-PC bilayers. 
 
3.2.4 Orientation of cholesterol 
The motion of cholesterol can be modeled as a fast rotation about the bilayer normal for 
the long molecular axis that in addition fluctuates in direction about a most probable orientation 
(tilt angle) offset from the normal [55]. Figure 5 (lower panel) shows the probability distribution 
calculated here for the angle a vector connecting the C13-C10 carbons, designating the alignment 
of the steroid moiety, makes with the bilayer normal in EPA-PC, DHA-PC, DPA-PC and OA-PC. 
A shift to larger angle and a broadening of the entire distribution accompanies the increase in 
disorder on replacing OA by each n-3 PUFA. It is clear, however, that there is little variation (< 
2°) in the most probable orientation, denoted by the maximum in the distribution, between the 
various systems (Table 3). This observation is consistent with 
2
H NMR work on  
 
 
OA-PC DPA-PC DHA-PC EPA-PC 
Most probable 
orientation 
14.5° 15.2° 15.8° 16.4° 
𝑆𝐶𝐷 0.37 0.36 0.35 0.35 
 
Table 3 Most probable orientation for a vector connecting the C13-C10 carbons and the 
order parameter for the 3α C-H bond of cholesterol incorporated at 20 mol% into OA-PC, 
DPA-PC, DHA-PC and EPA-PC. The standard errors in tilt angle are ±0.2° (OA-PC), ±0.8° 
(DPA-PC), ±0.3° (DHA-PC) and ±0.4° (EPA-PC); and in order parameter are <±0.005. 
 
[3α-2H1]cholesterol, an analog of the sterol labeled at the 3α position, incorporated at 50 mol% 
into PC bilayers with SA at the sn-1 position [56]. A tilt angle that is almost independent of the 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 
 
 25 
level of unsaturation for the sn-2 chain was revealed by an analysis of order parameters 
measured for the 3α C-2H bond in these experiments. The order parameters calculated from our 
simulations (Table 3), moreover, replicate the values measured by experiment for OA-PC (𝑆𝐶𝐷 = 
0.36) and DHA-PC (𝑆𝐶𝐷 = 0.35). As far as we know, experimental data on [3α-
2
H1]cholesterol 
in DPA-PC and EPA-PC do not exist. 
3.2.5 Interaction of cholesterol with acyl chains 
As a molecule that orders the membrane, cholesterol does so by interacting with the 
nearby fatty acid chains. The local lipid environment around the sterol molecule, thus, reflects 
how it interacts with the surrounding lipids. To analyze the packing around cholesterol of the 
fatty acyl chains in our study, a two-dimensional radial distribution function (RDF) 
𝑔(𝑟𝑖) =
𝑁(𝑟𝑖)
2𝜋𝑟𝑖𝜌(𝑟∞)
 (2) 
was generated [57]. In this equation 𝑟𝑖 is the distance from a selected atom on the steroid 
moiety (defined as the central atom) to the carbon atom on an acyl chain (sn-1 or -2) of the 
phospholipid, and 𝑁(𝑟𝑖) is the number of acyl chain carbons inside a bin at distance 𝑟𝑖 and at 
the same depth (±1 Å in the z direction) within the bilayer as the central atom. The term 
𝜌(𝑟∞) =
𝑁(𝑟∞)
2𝜋𝑟∞
  (3) 
represents the overall density of acyl chain atoms in the membrane, with r∞ set to 25 Å in 
practice. C10 and C13 were chosen as the central atom. Of the series of peaks in the RDF 
obtained (Figure 6), we focus on the first one that reflects the arrangement of the chains closest 
to a cholesterol molecule. 
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 Differences in the packing around cholesterol for the SA chain at the sn-1 position and for 
the OA and n-3 PUFA chains at the sn-2 position are immediately apparent in the RDF calculated 
with C10 for the central atom (Fig. 6, left panel). The RDF for the SA sn-1 chain has a  
 
Figure 6  Radial distribution function (RDF) for carbon atoms on the sn-1 and-2 chains of 
OA-PC, DPA-PC, DHA-PC and EPA-PC around the C10 (left panel) and C13 (right panel) atom 
on cholesterol. The carbon atoms on cholesterol and phospholipid are at the same depth (within 
±1 Å in z direction) as shown in the illustration on two sides. RDF plots relative to the C25 atom 
on cholesterol can be found in Figure S7 (Supporting Information). 
 
similar shape in each case. The first maximum at a distance of about 6 Å is a well-defined single 
peak. By contrast, the RDF for the unsaturated sn-2 chain differs in each case. In OA-PC the first 
maximum for the OA chain is reduced in height compared to the SA chain and, suggesting the 
presence of two peaks that do not precisely overlap, there is a hint of asymmetry. The reduction 
in height of the first maximum for the DPA chain in DPA-PC is more marked, as is its asymmetry. 
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There is further reduction in height and a better-defined separation into two peaks for the DHA 
chain in DHA-PC and the EPA chain in EPA-PC. These observations indicate that the PUFA, and 
to less extent OA, chains do not pack around cholesterol as tightly as the SA chain. The greater 
order of the saturated SA chain means that it adopts a more linear conformation that is able to lie 
parallel to the planar faces of the tetracyclic ring of the sterol. The higher disorder of the OA and, 
much more markedly, DPA, DHA and EPA chains produces an irregular configuration that is less 
compatible with close proximity, resulting in a distribution that is more spread out and uneven. 
We also calculated RDF lower down the steroid moiety by choosing C13 to be the central 
atom (Fig. 6, right panel). The first maximum for the sn-1 chain in all cases is less sharp than 
when C10 is the central atom. This change is due to the higher disorder that exists deeper in the 
bilayer where the C13 position is located. The same argument applies to the shape of the first 
maximum in the RDF for the sn-2 chains. The OA and DPA chains have a first maximum that is 
more clearly split into two peaks in the case of C13 position because the chains are more 
disordered. For DHA and EPA the difference between the C10 and C13 cases is less, which we 
attribute to near uniform high disorder that these chains possess throughout their entire length. A 
similar overall pattern is retained by RDF calculated about the C25 position in the tail of the 
sidechain of the sterol (Fig. S7, Supporting Information). Like at the C10 and C13 positions, the 
differential in height of the first maximum again signifies that all three n-3 PUFA and, to much 
less extent, OA at the sn-2 position do not pack as compactly as saturated SA at the sn-1 position. 
Peaks are not resolved within the maximum because there is greater symmetry in the distribution 
of phospholipid chains around the cholesterol sidechain. 
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The sterol ring on cholesterol is not symmetric. It has a planar structure that is flat on one 
side (α face) and has two methyl groups poking out on the other bumpy side (β face) (Fig. 7, 
upper panel). Given this molecular structure, the surrounding phospholipid chains are not  
 
Figure 7 Coordinate system (x',y',z') used in the number density profile (NDP) generation 
relative to the cholesterol molecule (upper panel) and an example of one slice illustrating the 
set-up of the NDP relative to cholesterol in OA-PC (lower panel). The color scale is the same as 
in Fig. 8. 
 
expected to pack equally with respect to the two faces. To map the azimuthal distribution, and so 
elaborate upon the RDF described above (Fig. 6), we generated a number density profile (NDP) 
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for the carbon atoms on the acyl chains with respect to an axis system (x',y',z') fixed in the 
cholesterol molecule. All 20 cholesterol molecules in our simulation were registered to a 
common frame of reference in which the C13 atom was chosen to be the origin, the C13-C18 
vector was fixed on the x' direction and C13-C10 vector was kept in the x'z' plane (Fig. 7, upper 
panel). The space around sterol molecules was then divided into bins 0.5 × 0.5 × 0.5 Å3 in size, 
and the number density of specified atoms on phospholipid molecules in each bin was counted 
through 180 ns of trajectory using a sampling rate of 50 frames per ns. Because of the consistent 
registration of coordinates, the NDP for all 20 cholesterol molecules could be simply added up. 
We computed in this way the NDP for the carbon atoms on the sn-1 or -2 chain of phospholipids 
within 1 nm distance from the origin on cholesterol in each system. A slice taken at z' = 0 (Fig. 7, 
lower panel) illustrates the set-up of the map of the spatial position of N(x',y') obtained. 
Two ring-like structures around the cholesterol molecule can be discerned in the NDP for 
the sn-1 (Fig. 8, left column) and -2 chains (Fig. 8, right column) on OA-PC, DPA-PC, DHA-PC 
and EPA-PC in the slice taken at z' = 0. The first (inner) ring, which is 10-12 Å in diameter, maps 
the distribution of the chains closest to the sterol and follows the shape of the flat α face on the 
left and the bumpy β face on the right. The second ring, which is approximately 20 Å in diameter, 
maps the distribution of the chains in the next layer out and is fuzzier. The pattern for the NDP is 
unique in each case. For OA-PC, the inner ring for the SA and OA chains is thinner and better 
defined compared to the corresponding chains in the polyunsaturated systems. In addition, the 
gap between the first and second rings is clearer for the saturated sn-1 chain than for the 
monounsaturated and, more markedly, polyunsaturated sn-2 chains. These general features 
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quantitatively agree with our assessment from the two-dimensional RDF plots - the packing of 
SA at the sn-1 position is tighter around cholesterol than OA and, even more so, DPA, DHA and 
EPA at the sn-2 position. 
 
Figure 8 NDP around cholesterol of the carbon atoms on the sn-1 (left column) and -2 
(right column) chains in OA-PC, DPA-PC, DHA-PC and EPA-PC. Slice is at the depth of the 
C13 atom on cholesterol. The color represents number of carbons found in 0.5 × 0.5 × 0.5 Å3 
bins in 180 ns by a sampling rate of 50 frames/ns. 
 
The NDP plots also probe how the density of the nearest neighbor chains in the first ring 
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varies with orientation around the sterol (Fig. 8). Regions of highest density, which indicate 
where a chain is most likely to be found, are apparent at the 1, 4, 9 and 11 o’clock positions for 
the SA chain and at the 4 and 7-10 o’clock positions for the OA chain in OA-PC. The region of 
high density for the latter chain at the 7-10 o’clock positions indicates that to some extent OA 
favors the flat surface of cholesterol. There is less heterogeneity in density for the more 
disordered chains in the n-3 PUFA containing membranes. In DPA-PC, the SA and DPA chains 
have highest density at the 1, 4 and 9 positions and the 4 and 11 positions, respectively. The 
regions of high density are less pronounced than in OA-PC and, in contrast to the OA chain, the 
DPA chain does not exhibit any preference for the flat face of the sterol. An almost homogenous 
distribution of density exists for the SA chain in DHA-PC, while regions of high density occur at 
the 1 and 9 o’clock positions for the DHA chain. As in DPA-PC, the regions of high density are 
not as distinct as in OA-PC. In EPA-PC, the most disordered of the three n-3 PUFA-containing 
membranes, the distribution of both SA and EPA chains ultimately becomes homogenous. 
The preference of the OA chain in OA-PC for the flat face of cholesterol exhibited in our 
NDP plots is contrary to the assessment made in simulations comparing RDF between the 
CH=CH on the sn-2 chain of the phospholipid and CH3 group at the C13 position on cholesterol 
in 1-palmitoyl-2-oleoylphosphatidycholine (POPC), which has saturated palmitic acid at the sn-1 
position and OA at the sn-2 position, and 1,2-dioleoylphosphatidylcholine (DOPC), which has 
OA at sn-1 and -2 position, bilayers [58]. In this earlier work greater disparity in height between 
the first and second peaks in the RDF plot for POPC compared to DOPC was attributed to OA 
preferring the bumpy face. It is an interpretation, however, made without the definitive insight 
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into orientation provided by our NDP plots. The higher density for DHA than SA seen in the 
inner ring closest to cholesterol of our NDP plots with DHA-PC is another observation that 
contradicts previously published simulations [23]. Probability density distributions around the 
sterol were calculated showing a shell-like structure, similar to the rings in the NDP plots 
reported here, in which solvation by SA over DHA is preferred. Possible reasons for the 
discrepancy between findings include the use in the current simulations of an updated version of 
the force field (CHARMM36p vs. CHARMM27) and of the more physically realistic NPT 
ensemble (as opposed to the constant-energy, constant-volume ensemble (NVE)). 
 
3.3 Biological implications 
 In conclusion, our MD simulations on DPA-PC, DHA-PC and EPA-PC demonstrate that 
all three n-3 PUFA increase disorder within a membrane and interact less favorably with 
cholesterol compared to monounsaturated OA in an OA-PC control. Differences between their 
molecular organization and interaction with cholesterol were revealed. EPA and DPA create most 
disorder and least disorder, respectively, while the effect of DHA is the same as DPA. The 
differential in order between them is modest (~5%), as quantified by the average order parameter 
of the SA chain at the sn-1 position, yet affects their ability to pack close to cholesterol. It is, 
moreover, of potential significance in understanding the dietary impact of the n-3 PUFA found in 
fish oils. 
 The lipid raft concept offers an example of potential sensitivity to the amount of disorder 
produced by a particular n-3 PUFA. According to this concept, nano-sized domains enriched in 
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sphingolipid and cholesterol that are liquid ordered (lo) and contain signaling proteins are 
surrounded by lipid that is liquid disordered (ld) in the plasma membrane [12]. When the rafts 
coalesce together, they become functionalized. A variation on this scenario has incorporation of 
n-3 PUFA into the phospholipids of the bulk lipid fine tuning the clustering of rafts via the 
increased differential in order between within raft and non-raft environments that results [18,59]. 
In support of this proposal, we recorded solid state 
2
H NMR spectra for deuterated analogs of 
EPA-, DHA- and OA-containing PC in mixtures with SM and cholesterol (1:1:1 mol) that were 
analyzed in terms of segregation into SM-rich/cholesterol-rich (raft-like) and 
PC-rich/cholesterol-poor (non-raft) domains [17]. Two-component spectra indicating slow 
exchange between domains larger in size (r > 35 nm) were obtained with EPA, whereas single 
component spectra indicating fast exchange between domains smaller in size (r < 45 nm) were 
obtained with OA. Consistent with a smaller reduction in order, spectra indicative of 
intermediate exchange between domains that fall in size between the limits estimated for EPA 
and OA were obtained with DHA. Whether signaling proteins in rafts are turned on or off, thus, 
may depend upon the n-3 PUFA incorporated into membrane phospholipids.  
 The smaller reduction in order produced by DPA compared to EPA is also a factor that 
should be borne in mind when assessing the efficacy of EPA. Specifically, fatty acid analyses of 
the composition of cells treated with EPA have shown that substantial elongation to DPA can 
occur [7]. In such cases, the increase in disorder anticipated in response to uptake of EPA would 
be reduced. The similar effect on membrane order, for instance, that was seen in B lymphoma 
cells treated with EPA and DHA was ascribed in part to elongation of EPA to DPA [37].  
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Additional biological implications for our work include informing the design of future 
clinical studies based on sound mechanistic research. EPA, DPA, and DHA are not, for example, 
bioequivalent for raft-dependent neuronal function in pre-clinical and clinical models [3]. 
Perhaps differences in molecular structure and interactions with plasma membrane cholesterol 
can partially explain the distinction in clinical efficacy. There are biological implications, 
furthermore, outside of lipid rafts. As an example, cardiolipin is a unique phospholipid to which 
n-3 PUFA are found to be esterified in the inner mitochondrial membrane [60]. Differences in 
molecular structure between DPA, DHA, and EPA could potentially influence binding kinetics to 
key respiratory enzymes in the mitochondrial inner membrane and thereby modulate 
mitochondrial bioenergetics. Plasmalogens, with an ether linkage at the sn-1 position and an ester 
linkage at the sn-2 position, are another class of phospholipid enriched in n-3 PUFA implicated 
in human disease [61]. Their packing, which is tighter than the di-acyl counterpart [62], is likely 
sensitive to the specific structure of a particular n-3 PUFA. Future studies will need to build on 
our predictions from simulations to address how EPA/DPA/DHA influences various models of 
membrane structure-function. 
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Graphical abstract 
  
 Highly disordered 
 n-3 PUFA deter close 
packing to cholesterol 
 
EPA>DHA≥DPA 
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Highlights 
 
 n-3 PUFA disorder membranes 
 Disordering depends upon number of double bonds and chain length, EPA (20:5) > DHA (22:6) ≥ 
DPA (22:5) 
 Higher disorder prevents closer packing with cholesterol 
 EPA, DHA and DPA are not equivalent in their interactions with membranes 
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